CN114451560A - 一种糖尿病患者用膳食组合物及其应用 - Google Patents
一种糖尿病患者用膳食组合物及其应用 Download PDFInfo
- Publication number
- CN114451560A CN114451560A CN202210154678.XA CN202210154678A CN114451560A CN 114451560 A CN114451560 A CN 114451560A CN 202210154678 A CN202210154678 A CN 202210154678A CN 114451560 A CN114451560 A CN 114451560A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- percent
- peptide
- protein
- oligopeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 64
- 235000007882 dietary composition Nutrition 0.000 title claims abstract description 31
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 36
- 235000010755 mineral Nutrition 0.000 claims abstract description 36
- 239000011707 mineral Substances 0.000 claims abstract description 36
- 235000018102 proteins Nutrition 0.000 claims abstract description 35
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 35
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 35
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 33
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 33
- 229940088594 vitamin Drugs 0.000 claims abstract description 31
- 229930003231 vitamin Natural products 0.000 claims abstract description 31
- 235000013343 vitamin Nutrition 0.000 claims abstract description 31
- 239000011782 vitamin Substances 0.000 claims abstract description 31
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 28
- 150000001875 compounds Chemical class 0.000 claims abstract description 27
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 21
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 20
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 17
- 235000005911 diet Nutrition 0.000 claims abstract description 15
- 150000002632 lipids Chemical class 0.000 claims abstract description 15
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims abstract description 14
- 230000037213 diet Effects 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 55
- 241000195620 Euglena Species 0.000 claims description 25
- 150000004676 glycans Chemical class 0.000 claims description 25
- 229920001282 polysaccharide Polymers 0.000 claims description 25
- 239000005017 polysaccharide Substances 0.000 claims description 25
- 241000220317 Rosa Species 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 22
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 18
- 235000012054 meals Nutrition 0.000 claims description 16
- 229920002774 Maltodextrin Polymers 0.000 claims description 15
- 239000005913 Maltodextrin Substances 0.000 claims description 15
- 229920000294 Resistant starch Polymers 0.000 claims description 15
- 229940035034 maltodextrin Drugs 0.000 claims description 15
- 235000021254 resistant starch Nutrition 0.000 claims description 15
- 229930003944 flavone Natural products 0.000 claims description 13
- 235000011949 flavones Nutrition 0.000 claims description 13
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 12
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- 241000361919 Metaphire sieboldi Species 0.000 claims description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 108010073771 Soybean Proteins Proteins 0.000 claims description 12
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 12
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 150000002212 flavone derivatives Chemical class 0.000 claims description 12
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 12
- 235000021119 whey protein Nutrition 0.000 claims description 12
- 239000005715 Fructose Substances 0.000 claims description 11
- 229930091371 Fructose Natural products 0.000 claims description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 11
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 8
- 244000105624 Arachis hypogaea Species 0.000 claims description 8
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 8
- 235000018262 Arachis monticola Nutrition 0.000 claims description 8
- 244000025254 Cannabis sativa Species 0.000 claims description 8
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 8
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 8
- 229920001202 Inulin Polymers 0.000 claims description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 8
- 235000009120 camo Nutrition 0.000 claims description 8
- 235000005607 chanvre indien Nutrition 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 235000008434 ginseng Nutrition 0.000 claims description 8
- 239000011487 hemp Substances 0.000 claims description 8
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 8
- 229940029339 inulin Drugs 0.000 claims description 8
- 235000020232 peanut Nutrition 0.000 claims description 8
- 241000255789 Bombyx mori Species 0.000 claims description 7
- 241000218236 Cannabis Species 0.000 claims description 7
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 7
- 229930003316 Vitamin D Natural products 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 7
- 239000011715 vitamin B12 Substances 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 235000019166 vitamin D Nutrition 0.000 claims description 7
- 239000011710 vitamin D Substances 0.000 claims description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 229940046008 vitamin d Drugs 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- 229910021555 Chromium Chloride Inorganic materials 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- 229930003448 Vitamin K Natural products 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 6
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 229960001781 ferrous sulfate Drugs 0.000 claims description 6
- 239000011790 ferrous sulphate Substances 0.000 claims description 6
- 235000003891 ferrous sulphate Nutrition 0.000 claims description 6
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 6
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 6
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- 229960003390 magnesium sulfate Drugs 0.000 claims description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 6
- 229940099596 manganese sulfate Drugs 0.000 claims description 6
- 239000011702 manganese sulphate Substances 0.000 claims description 6
- 235000007079 manganese sulphate Nutrition 0.000 claims description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 6
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 6
- 235000005152 nicotinamide Nutrition 0.000 claims description 6
- 239000011570 nicotinamide Substances 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 6
- 239000001103 potassium chloride Substances 0.000 claims description 6
- 235000011164 potassium chloride Nutrition 0.000 claims description 6
- 239000001508 potassium citrate Substances 0.000 claims description 6
- 229960002635 potassium citrate Drugs 0.000 claims description 6
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 6
- 235000011082 potassium citrates Nutrition 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 235000002639 sodium chloride Nutrition 0.000 claims description 6
- 239000011781 sodium selenite Substances 0.000 claims description 6
- 229960001471 sodium selenite Drugs 0.000 claims description 6
- 235000015921 sodium selenite Nutrition 0.000 claims description 6
- 229940001941 soy protein Drugs 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 235000019168 vitamin K Nutrition 0.000 claims description 6
- 239000011712 vitamin K Substances 0.000 claims description 6
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 6
- 229940046010 vitamin k Drugs 0.000 claims description 6
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 6
- 229960001763 zinc sulfate Drugs 0.000 claims description 6
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- 235000000832 Ayote Nutrition 0.000 claims description 5
- 240000004244 Cucurbita moschata Species 0.000 claims description 5
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 5
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 240000003183 Manihot esculenta Species 0.000 claims description 5
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- 241000382353 Pupa Species 0.000 claims description 5
- 240000002547 Rosa roxburghii Species 0.000 claims description 5
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- 235000021388 linseed oil Nutrition 0.000 claims description 5
- 239000000944 linseed oil Substances 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- 235000019895 oat fiber Nutrition 0.000 claims description 5
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 5
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 5
- 235000015136 pumpkin Nutrition 0.000 claims description 5
- 239000003549 soybean oil Substances 0.000 claims description 5
- 235000012424 soybean oil Nutrition 0.000 claims description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 4
- -1 compound vitamin Chemical class 0.000 claims description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 108010076119 Caseins Proteins 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- 244000098338 Triticum aestivum Species 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 239000000828 canola oil Substances 0.000 claims description 3
- 235000019519 canola oil Nutrition 0.000 claims description 3
- 244000013123 dwarf bean Species 0.000 claims description 3
- 235000021278 navy bean Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 239000002600 sunflower oil Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000000306 component Substances 0.000 claims 5
- 244000131316 Panax pseudoginseng Species 0.000 claims 2
- 235000012041 food component Nutrition 0.000 claims 1
- 239000005428 food component Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 28
- 210000004369 blood Anatomy 0.000 abstract description 28
- 230000001603 reducing effect Effects 0.000 abstract description 11
- 239000011785 micronutrient Substances 0.000 abstract description 7
- 235000013369 micronutrients Nutrition 0.000 abstract description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 5
- 239000011701 zinc Substances 0.000 abstract description 5
- 229910052725 zinc Inorganic materials 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 230000037208 balanced nutrition Effects 0.000 abstract description 3
- 235000019046 balanced nutrition Nutrition 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 229910052742 iron Inorganic materials 0.000 abstract description 3
- 235000003715 nutritional status Nutrition 0.000 abstract description 3
- 239000002366 mineral element Substances 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 235000016709 nutrition Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 235000013312 flour Nutrition 0.000 description 9
- 230000035764 nutrition Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 241000208340 Araliaceae Species 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 235000019710 soybean protein Nutrition 0.000 description 6
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002641 glycemic effect Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 3
- 229930186217 Glycolipid Natural products 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000020238 sunflower seed Nutrition 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- GHBSPIPJMLAMEP-UHFFFAOYSA-N 6-pentyloxan-2-one Chemical compound CCCCCC1CCCC(=O)O1 GHBSPIPJMLAMEP-UHFFFAOYSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000735566 Ribes burejense Species 0.000 description 2
- 235000016998 Ribes burejense Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000022558 protein metabolic process Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910001430 chromium ion Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 235000020802 micronutrient deficiency Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000019629 polyneuritis Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000007847 structural defect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000018648 unbalanced nutrition Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种糖尿病患者用膳食组合物及其应用,涉及食品技术领域。该糖尿病患者用膳食组合物的原料按质量百分数计包括:蛋白质10%‑30%、低聚肽1‑10%、碳水化合物40‑60%、膳食纤维1‑10%、脂质15‑35%、复合维生素0.05‑0.1%、复合矿物质0.2‑1%和药食同源成分1‑10%。其采用优质蛋白质和活性低聚肽提供充足氮源,低聚肽和药食同源成分能够协同辅助降血糖,此外,低聚肽还可以与钙、铁、锌等矿物质进行螯合进而使这些矿物质元素的吸收率增加,其可以有效改善糖尿病患者负氮平衡,迅速补充糖尿病患者所需的微量营养素,为糖尿病患者提供了均衡营养,能改善营养状况。
Description
技术领域
本发明涉及食品技术领域,具体而言,涉及一种糖尿病患者用膳食组合物及其应用。
背景技术
糖尿病是一种体内胰岛素相对或绝对不足或靶细胞对胰岛素敏感性降低,或胰岛素本身存在结构上的缺陷而引起的碳水化合物、脂肪和蛋白质代谢紊乱的一种慢性疾病。其主要特点是高血糖、糖尿。临床上表现为多饮、多食、多尿和体重减少,可使一些组织或器官发生形态结构改变和功能障碍,并发酮症酸中毒、肢体坏疽、多发性神经炎、失明和肾功能衰竭等。目前,糖尿病已成为严重危害人类生命健康的慢性代谢性疾病之一,其患病率呈现逐年增长的趋势。
世界卫生组织做过影响人类健康众多因素的评估,结果表明,膳食营养因素对健康的作用仅次于遗传因素,为13%,远大于医疗卫生条件因素的作用(仅为8%)。相对于药物的治疗,饮食治疗则更容易被患者接受,且依从性更好。糖尿病的治疗是包括饮食控制、运动处方、血糖监测、自我管理教育和药物治疗在内的综合治疗,饮食控制,也即医学营养治疗作为糖尿病治疗的“五驾马车”之一,成为了糖尿病患者的一种基础性治疗措施和手段。糖尿病患者用膳食食品就是针对糖尿病人群对营养素或膳食的特殊需要,专门加工配制而成的,糖尿病患者通过食用该类食品,在享受美食、保障营养充分的同时又能抑制血糖的升高,生活质量大为提高。
现有技术中为糖尿病患者设计的膳食食品很多,如专利文献CN109393463A适用糖尿病的特殊医学用途配方食品及制备方法和应用,公开了该配方食品由印奇果、藜麦、荷叶灰、丁位癸内酯、叶黄素酯、松子壳粉、风毛菊经过粉碎、提取、浓缩、混合等步骤制成。其可有效降低患者的血糖,缓解患者的临床症状。但其配方中缺少优质氮源、微量营养素等,无法满足糖尿病患者的营养和代谢需求,也难以增强患者的免疫能力,不能避免冠心病、肾病等并发症的发生。
鉴于此,特提出本发明。
发明内容
本发明的目的在于提供一种糖尿病患者用膳食组合物及其应用。
本发明是这样实现的:
第一方面,本发明提供一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:蛋白质10%-30%、低聚肽1-10%、碳水化合物40-60%、膳食纤维1-10%、脂质15-35%、复合维生素0.05-0.1%、复合矿物质0.2-1%和药食同源成分1-10%;
优选地,所述原料按质量百分数计包括:蛋白质15%-25%、低聚肽1-5%、碳水化合物45-55%、膳食纤维2-8%、脂质20-30%、复合维生素0.06-0.08%、复合矿物质0.4-0.8%和药食同源成分1-5%;
优选地,所述原料按质量百分数计包括:蛋白质20%、低聚肽3%、碳水化合物45.33%、膳食纤维5%、脂质23%、复合维生素0.07%、复合矿物质0.6%和药食同源成分3%。
在可选的实施方式中,所述蛋白质包括乳清蛋白、大豆蛋白和酪蛋白中的至少一种;
优选地,所述蛋白质包括乳清蛋白和大豆蛋白。
在可选的实施方式中,所述低聚肽包括花生肽、大米肽、小麦肽、蚕蛹肽、火麻仁肽、人参肽和地龙蛋白肽中的至少一种;
优选地,所述低聚肽包括花生肽、蚕蛹肽、火麻仁肽、人参肽和地龙蛋白肽中的至少一种;
优选地,所述低聚肽包括火麻仁肽和地龙蛋白肽中的至少一种。
在可选的实施方式中,所述药食同源成分为刺梨和裸藻中的至少一种;
优选地,所述刺梨为刺梨果粉、刺梨多糖或刺梨黄酮;
优选地,所述裸藻为裸藻粉或裸藻多糖。
在可选的实施方式中,所述复合维生素包括维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、叶酸、烟酸或烟酰胺、泛酸和生物素中的至少两种;
优选地,所述复合维生素由维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、叶酸、烟酸或烟酰胺、泛酸和生物素组成。
在可选的实施方式中,所述复合矿物质包括硫酸镁、硫酸锌、硫酸锰、硫酸亚铁、磷酸二氢钾、柠檬酸钾、硫酸铜、碳酸钙、碘化钾、氯化铬、氯化钠、氯化钾、亚硒酸钠的至少两种;
优选地,所述复合矿物质由硫酸镁、硫酸锌、硫酸锰、硫酸亚铁、磷酸二氢钾、柠檬酸钾、硫酸铜、碳酸钙、碘化钾、氯化铬、氯化钠、氯化钾、亚硒酸钠组成。
在可选的实施方式中,所述碳水化合物包括麦芽糊精、抗性淀粉、抗性糊精、南瓜粉、木薯粉、燕麦粉、白芸豆粉和果糖中的至少一种。
在可选的实施方式中,所述膳食纤维包括燕麦纤维、苹果纤维、菊粉、低聚异麦芽糖、低聚果糖和低聚木糖中的至少一种。
在可选的实施方式中,所述脂质包括中链甘油三酯粉、葵花籽油粉、大豆油粉、亚麻籽油粉和低芥酸菜籽油粉中的至少一种。
第二方面,本发明提供如前述实施方式任一项所述的糖尿病患者用膳食组合物在制备治疗或改善糖尿病患者负氮平衡的食品、保健品或药物中的应用。
本发明具有以下有益效果:
本申请提供的糖尿病患者用膳食组合物采用优质蛋白质和活性低聚肽提供充足氮源,低血糖生成指数(GI)的碳水化合物,膳食纤维、维生素和矿物质,为糖尿病患者提供营养和代谢需求,同时还可以保持血糖的平稳,进一步地,活性低聚肽和药食同源成分能够辅助降血糖,两者联用能够起到协同增效的作用,此外,低聚肽不仅仅能够提供氮源和辅助降血糖,还可以与钙、铁、锌等矿物质进行螯合进而使这些矿物质元素的吸收率增加。本申请提供的糖尿病患者用膳食组合物根据糖尿病患者的病理特征及消化、代谢特点来设计,可以有效改善糖尿病患者负氮平衡,迅速补充糖尿病患者所需的微量营养素,为糖尿病患者提供了均衡营养,能改善营养状况,辅助降低血糖水平和改善胰岛素敏感性,预防糖尿病并发症的发生的个性化定制食品,从而提高患者的生活质量。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
本发明提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:蛋白质10%-30%、低聚肽1-10%、碳水化合物40-60%、膳食纤维1-10%、脂质15-35%、复合维生素0.05-0.1%、复合矿物质0.2-1%和药食同源成分1-10%;
优选地,原料按质量百分数计包括:蛋白质15%-25%、低聚肽1-5%、碳水化合物45-55%、膳食纤维2-8%、脂质20-30%、复合维生素0.06-0.08%、复合矿物质0.4-0.8%和药食同源成分1-5%;
优选地,原料按质量百分数计包括:蛋白质20%、低聚肽3%、碳水化合物45.33%、膳食纤维5%、脂质23%、复合维生素0.07%、复合矿物质0.6%和药食同源成分3%。
其中,蛋白质包括但不限于乳清蛋白、大豆蛋白和酪蛋白中的至少一种;优选地,蛋白质包括乳清蛋白和大豆蛋白。
低聚肽包括但不限于花生肽、大米肽、小麦肽、蚕蛹肽、火麻仁肽、人参肽和地龙蛋白肽中的至少一种;优选地,低聚肽包括花生肽、蚕蛹肽、火麻仁肽、人参肽和地龙蛋白肽中的至少一种。
本申请中选用蛋白质和低聚肽为患者提供优质氮源,为患者提供营养支持。同时,低聚肽还可以起到辅助降血糖的生理功能,进一步地,低聚肽与钙、铁、锌等的螯合可使这些矿物质元素的吸收率增加。
药食同源成分为刺梨和裸藻中的至少一种;优选地,刺梨为刺梨果粉、刺梨多糖或刺梨黄酮;优选地,裸藻为裸藻粉或裸藻多糖。
本申请的原料中含有的药食同源成分可以协助糖尿病患者血糖的稳定,修复胰岛受损细胞,帮助糖尿病患者减少对药物的依赖。刺梨又名文先果、送春归,是蔷薇科蔷薇属落叶灌木,主要生长于我国西南山区,特别在贵州地区分布最为广泛。刺梨果实富含黄酮、多糖、维生素、超氧化物歧化酶和有机酸等营养元素,是一种典型的药食同源的水果。刺梨中黄酮、多糖具有抗氧化、降血糖、降血脂等功能活性。有学者对比了刺梨冻干粉、刺梨总多糖提取物和刺梨总黄酮提取物对2型糖尿病小鼠糖脂代谢紊乱的影响,结果表明三种物质均能改善2型糖尿病小鼠糖脂代谢紊乱,其中刺梨总黄酮提取物效果最优。裸藻又称眼虫,细胞中含有叶绿素,同时具有动物与植物两种特性。裸藻无细胞壁,易被消化。裸藻中含有丰富的营养成分,如蛋白质、多糖、维生素、矿物质等,近年来大量研究表明裸藻多糖具有降血糖、降血脂、降胆固醇作用,裸藻还能降低有害物对肝脏的损害,清除重金属,解决便秘等作用,是一类对糖尿病人群极为有益的新型食品原料。
本申请选用刺梨和裸藻中的至少一种作为药食同源组分加入到配方中,可以辅助降血糖,其机制为抑制α-葡萄糖苷酶和α-淀粉酶活性来降低葡萄糖水平。
复合维生素包括但不限于维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、叶酸、烟酸(或烟酰胺)、泛酸和生物素中的至少两种;优选地,复合维生素由维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、叶酸、烟酸(或烟酰胺)、泛酸和生物素组成。
由于糖尿病患者体内代谢障碍,造成多种微量元素的异常。其微量营养素缺乏的机制与糖尿病患者营养不均衡,饮食中摄入减少有关,也与患者在高血糖状态下机体的高代谢使得微量营养素潜在需要量增加有关,还与患者尿糖升高,引起渗透性利尿,导致部分微量元素的流失有关。对于血糖控制不良的重度糖尿病患者,由于其蛋白质代谢呈负氮平行,还会直接影响很多营养物质包括微量营养素的吸收。
本申请提供的糖尿病患者用膳食组合物中强化了微量营养元素,通过在配方中增加复合维生素,可以为糖尿病患者补充适量的维生素,其中,糖尿病患者适量补充维生素A能够保护胰岛β细胞免受自身免疫反应的攻击;摄入维生素C可以显著降低糖尿病的发病率;机体内维生素D能够通过降低胰岛素抵抗,促进胰岛素分泌,抑制机体炎症反应等改善患者血糖,减少并发症;与正常人群相比,糖尿病患者B族维生素水平有不同程度下降,尤其长期应用二甲双胍容易引起维生素B12水平的降低,糖尿病患者适量补充维生素B1具有控制血糖、减少尿蛋白、预防糖尿病肾病、辅助治疗糖尿病周围神经病变等作用。
复合矿物质包括但不限于硫酸镁、硫酸锌、硫酸锰、硫酸亚铁、磷酸二氢钾、柠檬酸钾、硫酸铜、碳酸钙、碘化钾、氯化铬、氯化钠、氯化钾、亚硒酸钠的至少两种,其用量参照《GB14880食品安全国家标准食品营养强化剂使用标准》的用量范围自由调整。
优选地,复合矿物质由硫酸镁、硫酸锌、硫酸锰、硫酸亚铁、磷酸二氢钾、柠檬酸钾、硫酸铜、碳酸钙、碘化钾、氯化铬、氯化钠、氯化钾、亚硒酸钠组成,其用量参照《GB14880食品安全国家标准食品营养强化剂使用标准》的用量范围自由调整。
此外,本申请的配方中还提供了复合矿物质,其中,镁是多种糖代谢酶的辅助因子,糖尿病患者普遍存在血镁水平下降;从而引起相应酶的功能受损,导致胰岛素抵抗;三价铬离子可以通过调节葡萄糖耐量因子,提高胰岛素的敏感性,加速血糖转运与利用,是维持糖脂代谢所必需的微量元素;糖尿病患者血清锌水平普遍缺乏,胰岛素的分子结构中缺乏锌离子会导致其活性减弱甚至变性,膳食中适当补充锌可以降低罹患糖尿病的风险;硒元素具有增强免疫力,调节机体维生素吸收等作用,同时硒元素在体内应对氧化应激方面发挥重要作用,能参与清除体内自由基,有效缓解糖尿病患者胰岛的氧化应激。
碳水化合物包括但不限于麦芽糊精、抗性淀粉、抗性糊精、南瓜粉、木薯粉、燕麦粉、白芸豆粉和果糖中的至少一种。例如,碳水化合物的加入形式包括:麦芽糊精、抗性淀粉+麦芽糊精、麦芽糊精+南瓜粉+果糖、木薯粉+燕麦粉+白芸豆粉+果糖等等,其中除果糖外的其他碳水化合物可以单独使用也可以复配使用,而果糖在使用时更优选与其他碳水化合物组合使用。本申请中所选的碳水化合物来源均为低血糖生成指数的原料,既可以提供糖尿病患者所需要的能量,又能保持血糖的平稳。
膳食纤维包括但不限于燕麦纤维、苹果纤维、菊粉、低聚异麦芽糖、低聚果糖和低聚木糖中的至少一种。脂质但不限于包括中链甘油三酯粉、葵花籽油粉、大豆油粉、亚麻籽油粉和低芥酸菜籽油粉中的至少一种。膳食纤维和脂质可以为糖尿病患者提供营养和代谢需求。
本申请提供的糖尿病患者用膳食组合物采用优质蛋白质和低聚肽提供充足氮源,低血糖生成指数(GI)的碳水化合物、膳食纤维、维生素和矿物质能够为糖尿病患者提供营养和代谢需求,此外,本申请中的低聚肽和药食同源成分可以辅助降血糖,为糖尿病患者提供了均衡营养,能改善营养状况,辅助降低血糖水平和改善胰岛素敏感性,预防糖尿病并发症的发生的个性化定制食品,从而提高患者的生活质量。上述糖尿病患者用膳食组合物可以广泛应用于制备治疗或改善糖尿病患者负氮平衡的食品、保健品或药物中。
以下结合实施例对本发明的特征和性能作进一步的详细描述。
实施例1
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:乳清蛋白15%、大豆蛋白5%、花生肽3%、抗性淀粉4%、麦芽糊精20%、木薯粉18.33%、燕麦纤维5%、菊粉3%、亚麻籽油23%、复合维生素0.07%、复合矿物质0.6%、裸藻多糖3%。将上述原料均匀混合,即得。
实施例2
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:乳清蛋白16%、酪蛋白4%、地龙蛋白肽3%、抗性糊精3%、麦芽糊精21%、白芸豆粉19.33%、苹果纤维4%、菊粉3%、葵花籽油23%、复合维生素0.07%、复合矿物质0.6%、刺梨多糖3%。将上述原料均匀混合,即得。
实施例3
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:乳清蛋白15%、大豆蛋白5%、火麻仁肽3%、抗性糊精4%、麦芽糊精19.5%、南瓜粉23.33%、低聚木糖3.5%、大豆油23%、复合维生素0.07%、复合矿物质0.6%、刺梨黄酮3%。将上述原料均匀混合,即得。
实施例4
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:酪蛋白10%、大豆蛋白10%、人参肽3%、抗性淀粉3%、麦芽糊精23.83%、果糖20%、低聚异麦芽糖3.5%、葵花籽油23%、复合维生素0.07%、复合矿物质0.6%、刺梨黄酮1.5%、裸藻多糖1.5%。将上述原料均匀混合,即得。
实施例5
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:乳清蛋白15%、大豆蛋白5%、火麻仁肽3%、抗性淀粉4.5%、麦芽糊精17.33%、果糖23.5%、菊粉2%、低聚果糖3%、低芥酸菜籽油23%、复合维生素0.07%、复合矿物质0.6%、刺梨黄酮1.2%、刺梨多糖0.8%、裸藻多糖1%。将上述原料均匀混合,即得。
实施例6
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:乳清蛋白14%、大豆蛋白6%、火麻仁肽1.8%、花生肽1.2%、抗性淀粉5%、麦芽糊精16%、果糖23.33%、菊粉2.5%、低聚果糖3.5%、亚麻籽油18%、中链甘油三酯5%、复合维生素0.07%、复合矿物质0.6%、刺梨黄酮-2%、刺梨多糖1%。将上述原料均匀混合,即得。
实施例7
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:酪蛋白10%、地龙蛋白肽10%、抗性淀粉8%、麦芽糊精12%、果糖22.9%、菊粉2%、低聚果糖3%、葵花籽油粉11%、中链甘油三酯10%、复合维生素0.1%、复合矿物质1%、刺梨果粉3%、刺梨多糖3%、裸藻多糖4%。将上述原料均匀混合,即得。
实施例8
本实施例提供了一种糖尿病患者用膳食组合物,其原料按质量百分数计包括:乳清蛋白13%、大豆蛋白7%、蚕蛹肽5%、人参肽5%、麦芽糊精27.75%、抗性淀粉20%、燕麦纤维1%、苹果纤维1%、大豆油粉18%、复合维生素0.05%、复合矿物质0.2%、刺梨果粉0.5%、裸藻多糖1.5%。将上述原料均匀混合,即得。
实施例9
本实施例提供了一种糖尿病患者用膳食组合物,其基本与实施例5相同,区别在于,本实施例中使用的低聚肽为地龙蛋白肽。
实施例10
本实施例提供了一种糖尿病患者用膳食组合物,其基本与实施例5相同,区别在于,本实施例中使用的低聚肽为火麻仁肽1.5%和地龙蛋白肽1.5%。
对比例1
本对比例与实施例5基本相同,区别在于,省略了实施例5中的火麻仁肽,并采用等同量的抗性淀粉补足。
对比例2
本对比例与实施例5基本相同,区别在于,省略了实施例5中的复合矿物质,并采用等同量的抗性淀粉补足。
对比例3
本对比例与实施例5基本相同,区别在于,省略了实施例5中的火麻仁肽和复合矿物质,并采用等同量的抗性淀粉补足。
对比例4
本对比例与实施例5基本相同,区别在于,省略了实施例5中的刺梨黄酮、刺梨多糖和裸藻多糖,并采用等同量的抗性淀粉补足。
对比例5
本对比例与实施例5基本相同,区别在于,省略了实施例5中的火麻仁、刺梨黄酮、刺梨多糖和裸藻多糖,并采用等同量的抗性淀粉补足。
对比例6
本对比例与实施例5基本相同,区别在于,本对比例中火麻仁肽的用量为15%,麦芽糊精的用量为5.33%。
以下通过人体试食试验进一步说明本发明的有益效果。
1、试食人群的选择:选择800例糖尿病患者,分成16组,即实施例1组-实施例10组、对比例1组-对比例6组,每组50例。其中Ⅰ型300例,Ⅱ型500例;其中男400例,女400例。
2、试食样品:按以上实施例1-10以及对比例1-6配方及工艺制备。
3、试食方法:各试验组试食人群食用对应试食样品,每日一次,于早餐后3小时食用,每次25g,食用方法及食用量各组均相同,连续观察一个月后检测,统计各组平均血糖值。
4、结果
从以上结果可知,试验人群食用各对应试食样品后血糖生成值降低,降血糖效果较佳。试食30天后试食前1小时血糖较未试验时血糖有明显降低,试食前后1小时血糖值波动较小,说明本发明提供的糖尿病患者用膳食食品具有确切的辅助降糖尿作用,本发明糖尿病患者用膳食食品还能给予糖尿病病人充分营养支持与保障,保证糖尿病患者对能量的需求,是糖尿病患者不可多得的一类膳食食品。
综上所述,本申请提供的糖尿病患者用膳食组合物采用优质蛋白质和活性低聚肽提供充足氮源,低血糖生成指数(GI)的碳水化合物,膳食纤维、维生素和矿物质,为糖尿病患者提供营养和代谢需求,同时还可以保持血糖的平稳,进一步地,活性低聚肽和药食同源成分能够辅助降血糖,两者联用能够起到协同增效的作用,此外,低聚肽不仅仅能够提供氮源和辅助降血糖,还可以与钙、铁、锌等矿物质进行螯合进而使这些矿物质元素的吸收率增加。本申请提供的糖尿病患者用膳食组合物根据糖尿病患者的病理特征及消化、代谢特点来设计,可以有效改善糖尿病患者负氮平衡,迅速补充糖尿病患者所需的微量营养素,为糖尿病患者提供了均衡营养,能改善营养状况,辅助降低血糖水平和改善胰岛素敏感性,预防糖尿病并发症的发生的个性化定制食品,从而提高患者的生活质量。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种糖尿病患者用膳食组合物,其特征在于,其原料按质量百分数计包括:蛋白质10%-30%、低聚肽1-10%、碳水化合物40-60%、膳食纤维1-10%、脂质15-35%、复合维生素0.05-0.1%、复合矿物质0.2-1%和药食同源成分1-10%;
优选地,所述原料按质量百分数计包括:蛋白质15%-25%、低聚肽1-5%、碳水化合物45-55%、膳食纤维2-8%、脂质20-30%、复合维生素0.06-0.08%、复合矿物质0.4-0.8%和药食同源成分1-5%;
优选地,所述原料按质量百分数计包括:蛋白质20%、低聚肽3%、碳水化合物45.33%、膳食纤维5%、脂质23%、复合维生素0.07%、复合矿物质0.6%和药食同源成分3%。
2.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述蛋白质包括乳清蛋白、大豆蛋白和酪蛋白中的至少一种;
优选地,所述蛋白质包括乳清蛋白和大豆蛋白。
3.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述低聚肽包括花生肽、大米肽、小麦肽、蚕蛹肽、火麻仁肽、人参肽和地龙蛋白肽中的至少一种;
优选地,所述低聚肽包括花生肽、蚕蛹肽、火麻仁肽、人参肽和地龙蛋白肽中的至少一种;
优选地,所述低聚肽包括火麻仁肽和地龙蛋白肽中的至少一种。
4.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述药食同源成分为刺梨和裸藻中的至少一种;
优选地,所述刺梨为刺梨果粉、刺梨多糖或刺梨黄酮;
优选地,所述裸藻为裸藻粉或裸藻多糖。
5.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述复合维生素包括维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、叶酸、烟酸或烟酰胺、泛酸和生物素中的至少两种;
优选地,所述复合维生素由维生素A、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、维生素D、维生素E、维生素K、叶酸、烟酸或烟酰胺、泛酸和生物素组成。
6.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述复合矿物质包括硫酸镁、硫酸锌、硫酸锰、硫酸亚铁、磷酸二氢钾、柠檬酸钾、硫酸铜、碳酸钙、碘化钾、氯化铬、氯化钠、氯化钾、亚硒酸钠的至少两种;
优选地,所述复合矿物质由硫酸镁、硫酸锌、硫酸锰、硫酸亚铁、磷酸二氢钾、柠檬酸钾、硫酸铜、碳酸钙、碘化钾、氯化铬、氯化钠、氯化钾、亚硒酸钠组成。
7.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述碳水化合物包括麦芽糊精、抗性淀粉、抗性糊精、南瓜粉、木薯粉、燕麦粉、白芸豆粉和果糖中的至少一种。
8.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述膳食纤维包括燕麦纤维、苹果纤维、菊粉、低聚异麦芽糖、低聚果糖和低聚木糖中的至少一种。
9.根据权利要求1所述的糖尿病患者用膳食组合物,其特征在于,所述脂质包括中链甘油三酯粉、葵花籽油粉、大豆油粉、亚麻籽油粉和低芥酸菜籽油粉中的至少一种。
10.如权利要求1-9任一项所述的糖尿病患者用膳食组合物在制备治疗或改善糖尿病患者负氮平衡的食品、保健品或药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210154678.XA CN114451560A (zh) | 2022-02-21 | 2022-02-21 | 一种糖尿病患者用膳食组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210154678.XA CN114451560A (zh) | 2022-02-21 | 2022-02-21 | 一种糖尿病患者用膳食组合物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114451560A true CN114451560A (zh) | 2022-05-10 |
Family
ID=81416002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210154678.XA Pending CN114451560A (zh) | 2022-02-21 | 2022-02-21 | 一种糖尿病患者用膳食组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114451560A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117643375A (zh) * | 2023-12-21 | 2024-03-05 | 中山大学孙逸仙纪念医院 | 一种适合t2dm强化治疗后维持的低gl膳食配方及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496580A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种供糖尿病患者食用含短肽的特殊膳食用食品配方 |
CN104856003A (zh) * | 2015-04-23 | 2015-08-26 | 劲膳美生物科技股份有限公司 | 糖尿病非全营养配方食品 |
CN106616998A (zh) * | 2016-12-30 | 2017-05-10 | 北京康比特体育科技股份有限公司 | 一种营养代餐的组合物及其应用 |
CN107822116A (zh) * | 2017-11-13 | 2018-03-23 | 福建省水产研究所(福建水产病害防治中心) | 适用于糖尿病患者的海洋短肽型特殊医学用途配方食品 |
CN110192583A (zh) * | 2019-03-19 | 2019-09-03 | 上海迦林生物科技有限公司 | 具有促进肠道健康、控制体重和提高免疫的组合物及应用 |
CN110720627A (zh) * | 2019-11-05 | 2020-01-24 | 深圳市华大农业应用研究院 | 辅助调节血糖的代餐组合物及其饮食方法 |
CN111888431A (zh) * | 2020-08-17 | 2020-11-06 | 江西优培文化传媒有限公司 | 一种治疗糖尿病的组合物及其制备方法 |
-
2022
- 2022-02-21 CN CN202210154678.XA patent/CN114451560A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101496580A (zh) * | 2008-01-28 | 2009-08-05 | 中国食品发酵工业研究院 | 一种供糖尿病患者食用含短肽的特殊膳食用食品配方 |
CN104856003A (zh) * | 2015-04-23 | 2015-08-26 | 劲膳美生物科技股份有限公司 | 糖尿病非全营养配方食品 |
CN106616998A (zh) * | 2016-12-30 | 2017-05-10 | 北京康比特体育科技股份有限公司 | 一种营养代餐的组合物及其应用 |
CN107822116A (zh) * | 2017-11-13 | 2018-03-23 | 福建省水产研究所(福建水产病害防治中心) | 适用于糖尿病患者的海洋短肽型特殊医学用途配方食品 |
CN110192583A (zh) * | 2019-03-19 | 2019-09-03 | 上海迦林生物科技有限公司 | 具有促进肠道健康、控制体重和提高免疫的组合物及应用 |
CN110720627A (zh) * | 2019-11-05 | 2020-01-24 | 深圳市华大农业应用研究院 | 辅助调节血糖的代餐组合物及其饮食方法 |
CN111888431A (zh) * | 2020-08-17 | 2020-11-06 | 江西优培文化传媒有限公司 | 一种治疗糖尿病的组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117643375A (zh) * | 2023-12-21 | 2024-03-05 | 中山大学孙逸仙纪念医院 | 一种适合t2dm强化治疗后维持的低gl膳食配方及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ruan et al. | Tartary buckwheat: An under-utilized edible and medicinal herb for food and nutritional security | |
CN101878790B (zh) | 一种糖尿病专用强化营养面粉及其制备方法 | |
CN102648752B (zh) | 一种适于膳食失衡人群有降血糖功能的工程米及制备方法 | |
CN103431392B (zh) | 一种供糖尿病患者食用的复合海洋特膳食品 | |
CN111728202A (zh) | 一种适用于糖尿病患者的食品组合物及制备方法 | |
JP2006519867A (ja) | 治療用組成物 | |
CN108208802A (zh) | 一种适合糖尿病患者食用的特殊膳食及其制备方法 | |
CN102613453B (zh) | 一种用于糖尿病患者的海洋生物型肠内营养制剂及其制备方法和用途 | |
CN102113652A (zh) | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 | |
CN108813590A (zh) | 一种适合糖尿病患者的低gi配方食品及其制备方法 | |
CN114451560A (zh) | 一种糖尿病患者用膳食组合物及其应用 | |
Tiwari et al. | Effect of finger millet (Eleusine coracana) buns supplementation on serum glucose and serum lipids level in type 2 diabetics | |
CN107223981B (zh) | 含大豆多肽阿格拉欣的组合物及其制备方法 | |
EP2294932B1 (en) | Carbohydrate mixture and the use thereof for preparing a product for oral or enteral nutrition | |
CN115998838B (zh) | 一种具有降血糖协同增效作用的组合物及其应用 | |
EP3574912B1 (en) | Composition for treating diabetic disease | |
Foster et al. | Combined Inositol Hexakisphosphate and Inositol Supplement Consumption Improves Serum Alpha-Amylase Activity and Hematological Parameters in Streptozotocin-Induced Type 2 Diabetic Rats | |
CN101524153A (zh) | 益于糖尿病人的保健小麦面粉 | |
CN110101020A (zh) | 一种糖尿病全营养素配方食品 | |
CN104982768B (zh) | 一种适合肾病病人能量补充的果冻及其制作方法 | |
CN114271413A (zh) | 一种提高草鱼糖利用率的饲料及其制备和应用 | |
CN114532544A (zh) | 降糖、控糖的谷果植物肽固体饮料 | |
CN113598365A (zh) | 一种用于肺损伤病患的特殊医学用途全营养配方食品 | |
CN106858578A (zh) | 适于糖尿病患者食用的营养面粉 | |
Jáquez et al. | Efficacy of Diabetes-Specific Formulas as Meal Replacements in Diabetic Pa-tients: An Overview |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |